Regeneron Pharmaceuticals, Inc. (REGN) - Financials, balance sheet (quarterly)

522.27002 USD

10.35

2.02%

Last update Jun 24, 3:59 PM EDT

Pre-market

Day range

522.27002

515.78998

527.45001

Previous close

511.92001

Open

515.78998

Access this stock data via API

Regeneron Pharmaceuticals, Inc.

522.27

10.35

2.02%

Financials

Balance sheet

Fiscal date	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total assets	37.5B	37.8B	37.4B	36.1B
Current assets	17.6B	18.7B	19.3B	19.1B
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	3.1B	2.5B	2.0B	1.9B
Other short term investments	5.3B	6.5B	7.8B	7.9B
Accounts receivable	5.6B	6.2B	6.1B	5.7B
Other receivables	—	—	—	—
Inventory	3.2B	3.1B	3.0B	2.9B
Prepaid assets	—	—	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	468.9M	349.2M	412M	681.9M
Non current assets	20.0B	19.1B	18.1B	17.0B
Properties	—	1.5B	—	—
Land and improvements	—	288.2M	—	—
Machinery furniture equipment	—	654.6M	—	—
Construction in progress	—	1.7B	—	—
Leases	—	154.5M	—	—
Accumulated depreciation	—	-2.3B	—	—
Goodwill	1.2B	1.1B	1.1B	1.1B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	—	1.1B	—	—
Investments and advances	9.3B	8.9B	8.5B	7.7B
Other non current assets	4.8B	4.5B	4.1B	3.9B
Total liabilities	8.2B	8.4B	8.1B	7.9B
Current liabilities	3.6B	3.9B	3.7B	3.5B
Accounts payable	705.5M	789.5M	497.3M	561.7M
Accrued expenses	2.2B	2.3B	2.5B	2.4B
Short term debt	—	—	—	—
Deferred revenue	619.3M	627.7M	627.2M	586M
Tax payable	—	213.2M	—	—
Pensions	—	—	—	—
Other current liabilities	—	—	—	—
Non current liabilities	4.6B	4.5B	4.5B	4.4B
Long term provisions	—	—	—	—
Long term debt	2.7B	2.7B	2.7B	2.7B
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	1.7B	1.6B	1.5B	1.5B
Shareholders equity
Common stock	100K	100K	100K	100K
Retained earnings	32.4B	31.7B	30.8B	29.4B
Other shareholders equity	29.1M	-7.9M	60.2M	-69.9M
Total shareholders equity	29.4B	29.4B	29.3B	28.2B
Additional paid in capital	13.2B	12.9B	12.7B	12.3B
Treasury stock	16.2B	15.2B	14.2B	13.5B
Minority interest	—	—	—	—